GXO Logistics Inc vs MiniMed Group Inc. Common Stock — how do they compare? GXO Logistics Inc trades at $46.63 (market cap $5.32B), while MiniMed Group Inc. Common Stock trades at $19.69 (market cap $5.57B). The key difference: GXO Logistics Inc and MiniMed Group Inc. Common Stock are close in size by market cap, and MiniMed Group Inc. Common Stock is trading nearer its 52-week high, GXO Logistics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GXO Logistics Inc for 28 Days and MiniMed Group Inc. Common Stock for 1 Days on average.
| GXO | MMED | |
|---|---|---|
Market Cap | $5.32B | $5.57B |
Volume | 1,255,816 | 23,336,073 |
Sector | Industrials | Health |
52-Week High | $65.59 | $23.84 |
52-Week Low | $44.17 | $10.80 |
Typical Hold Time | 28 Days | 1 Days |
Enterprise Value | $10.67B | $5.37B |
Signals from Pluang's Aura AI — not financial advice
GXO trades at $46.47, up 1.04% with neutral technical indicators and strong analyst support. The company shows improving fundamentals with Q2 2026 revenue of $3.4 billion (up 4% YoY) and three consecutive earnings beats. Recent strategic partnerships with Columbia Sportswear and technology investments in labor management systems position GXO for operational efficiency gains. The stock trades at a P/E of 41.03 and P/S of 0.39, reflecting growth expectations amid modest current profitability.
GXO presents a compelling growth story with 88.9% analyst buy ratings and a $66.67 consensus price target (43% upside). However, margin compression remains a concern as new business wins show lower incremental profitability. The company's expansion in aerospace/defense and European logistics markets provides growth catalysts, but investors should monitor execution on the 6% EBIT margin target and supply chain industry headwinds.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
GXO is the world's largest pure-play contract logistics provider. It offers cutting-edge supply chain solutions, including automated warehousing and fulfillment, for global blue-chip companies.
Read more on GXO →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →